News Release 

Scientists reveal COVID-19 news, next frontier in fighting substance abuse, more

Register for online access to cutting-edge science at Experimental Biology 2021, April 27-30

Experimental Biology

Scientific Meeting Announcement

Contact: media@experimentalbiology.org

Want to find out the latest insights into COVID-19, explore new medicines for fighting substance abuse or delve into cultural challenges facing the scientific community? The Experimental Biology (EB) 2021 meeting is your source for the latest research and discussion on today's hot topics in science and medicine.

EB 2021, to be held April 27-30, is the annual meeting of five scientific societies, bringing together thousands of scientists and 25 guest societies in one interdisciplinary event.

To request a press pass, please complete a Press Registration Form. Approved reporters receive complimentary meeting registration and full access to our virtual newsroom. We encourage advance registration as it may take up to a day to receive access once the meeting begins.

View the program to get the latest information on planned scientific sessions and events.

Highlights from EB 2021 include:

Understanding and containing the COVID-19 pandemic -- Short lightning talks will cover mechanisms behind COVID-19 infections, predicting outcomes based on underlying conditions, and the state of testing. This American Society for Investigative Pathology Expert Roundtable will also discuss controlling COVID-19 in meat and poultry processing plants, genotyping emerging variants, and current and emerging treatments. Talks will be followed by a live moderated Q&A session. (2-5 p.m. Friday, April 30) (more information)

Gender differences in COVID-19 -- SARS-CoV-2, the virus that causes COVID-19, is showing severe illness and mortality in men, a pattern opposite to influenza outbreaks in which sickness and death are often higher in women. This American Physiological Society symposium will address key findings regarding sex differences in the progression of SARS-CoV-2 infection and COVID-19. (10-11:30 a.m. Thursday, April 29) (more information)

Orchestrating a 3D symphony of stem cells for regeneration -- This American Association for Anatomy session will examine the latest advances in 3D tissue engineering, including new applications for nanocomposites and the potential of organ printing for regenerative medicine. Speakers also will cover how 3D printing of cells and other materials can be used to construct tissue and influence cell behavior. (10-11 a.m. Tuesday, April 27) (more information)

Creating a culture of wellness in science -- This American Society for Biochemistry and Molecular Biology symposium will examine best practices for mentorship, how to promote mental well-being and ways to prevent and overcome harassment. (11:15 a.m. Tuesday, April 27) (more information). A related talk by Sharon Milgram, director of intramural training and education at the National Institutes of Health, will cover painful and important lessons about resilience and wellness for scientists. (5 p.m. Tuesday, April 27) (more information). Helen Kaiser and Michael Diaz from the University of California San Diego will also give a related talk (11:45 a.m. Thursday, April 29) (more information).

Real world perspective on the substance use epidemic -- Substance use disorders have increased during the COVID-19 pandemic. Although the opioid epidemic may receive the most media attention, misuse of stimulant drugs is also a significant problem. During the American Society for Pharmacology and Experimental Therapeutics President's Symposium, experts will provide an update on current substance use disorder challenges and examine emerging approaches for developing more effective medications. (10-11:30 a.m. Wednesday, April 28) (more information)

EB host societies are the American Association for Anatomy, American Physiological Society, American Society for Biochemistry and Molecular Biology, American Society for Investigative Pathology and American Society for Pharmacology & Experimental Therapeutics.

#expbio | EB on Facebook | EB on Twitter (@expbio)

###

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.